Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi




http://scihub22266oqcxt.onion/
suck pdf from google scholar
16563245!ä!16563245

suck abstract from ncbi


Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538

Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538

Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\16563245.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117
pmid16563245      Zhonghua+Xin+Xue+Guan+Bing+Za+Zhi 2005 ; 33 (11): 995-7
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Effects of carvedilol on neurohormone and magnesium metabolism in patients with chronic heart failure #MMPMID16563245
  • Lin XY; Xiao LZ; Gao LJ; Zhang HF
  • Zhonghua Xin Xue Guan Bing Za Zhi 2005[Nov]; 33 (11): 995-7 PMID16563245show ga
  • OBJECTIVE: To investigate the effects of carvedilol on neurohormone and magnesium metabolism in patients with chronic heart failure (CHF). METHODS: Fifty-seven patients with CHF were divided into two groups randomly: received conventional treatment alone or combined with carvedilol for 8 weeks, respectively. Urine magnesium excretion (UME), plasma levels of magnesium (PMC), norepinephrine (NE), angiotensin-II (Ang-II), aldosterone (ALD), plasma renin activity (PRA) and peripheral monocyte magnesium content (MMC) were measured before and after treatments. Twenty-six health persons were selected as normal subjects. RESULTS: There was a significant increase in UME and plasma concentrations of NE, ALD, Ang-II and PRA, and a significant decrease in MMC in patients with CHF, compared with the control group (P < 0.01). UME was positively correlated with ALD, Ang-II, PRA r = 0.41, 0.42, 0.38, respectively (P < 0.01). These parameters significantly improved after carvedilol (P < 0.05). CONCLUSION: Carvedilol decreases significantly plasma concentrations of neurohormone and urine magnesium excretion, and increases cell magnesium content in patients with CHF.
  • |Adrenergic beta-Antagonists/*therapeutic use[MESH]
  • |Adult[MESH]
  • |Aged[MESH]
  • |Aldosterone/blood[MESH]
  • |Angiotensin II/blood[MESH]
  • |Carbazoles/*therapeutic use[MESH]
  • |Carvedilol[MESH]
  • |Female[MESH]
  • |Heart Failure/*blood/*drug therapy[MESH]
  • |Humans[MESH]
  • |Magnesium/blood[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Natriuretic Peptide, Brain/blood[MESH]
  • |Norepinephrine/blood[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box